Evidence supporting the use of: Apocynin
For the health condition: Diabetic Retinopathy

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Apocynin is a naturally occurring compound found in the roots of Picrorhiza kurroa and is known for its anti-inflammatory and antioxidant properties, primarily through inhibition of NADPH oxidase, an enzyme complex involved in the generation of reactive oxygen species (ROS). In the context of Diabetic Retinopathy (DR), oxidative stress plays a significant role in the development and progression of retinal vascular damage. Several preclinical studies (in vitro and animal models) have demonstrated that apocynin can reduce retinal oxidative stress, inflammation, and vascular leakage associated with DR. For instance, animal studies show that apocynin treatment decreases levels of ROS, inflammatory cytokines, and vascular endothelial growth factor (VEGF) in diabetic rats, thereby protecting against retinal damage.

However, clinical evidence in humans is lacking. Most data supporting apocynin’s use for DR come from experimental models rather than human trials. No large-scale, randomized clinical trials have confirmed its efficacy or safety in people with diabetic retinopathy. Thus, while there is a plausible scientific rationale and promising preclinical data, the evidence remains preliminary and insufficient to fully endorse apocynin for this indication in clinical practice. The rating reflects this gap, emphasizing the need for further research before apocynin can be recommended as a standard or adjunctive therapy for diabetic retinopathy.

More about apocynin
More about Diabetic Retinopathy

Products containing apocynin

We currently have no products on Vitabase that contain this ingredient.